Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-22-009282
Filing Date
2022-04-15
Accepted
2022-04-15 13:02:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2022defa14a.htm DEFA14A 24018
2 image_0a.jpg GRAPHIC 13627
3 img1a.jpg GRAPHIC 1544303
4 img2a.jpg GRAPHIC 261341
  Complete submission text file 0001628280-22-009282.txt   2528825
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35558 | Film No.: 22829525
SIC: 2836 Biological Products, (No Diagnostic Substances)